{"transactions":[{"id":776226,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-18T20:05:08.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":2239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined."}],"balance_after":2239,"derivative":{"exercise_price":103.38,"exercise_date":"2027-05-14","expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":2239},"source":{"system":"sec-edgar","filing":"0001193125-26-228897","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526228897/ownership.xml","form_type":"4"}},{"id":776225,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:05:08.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Konstantinov was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":3889,"source":{"system":"sec-edgar","filing":"0001193125-26-228897","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526228897/ownership.xml","form_type":"4"}},{"id":1144326,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T00:26:29.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":1800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full on the earlier of May 15, 2026, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined."}],"balance_after":1800,"derivative":{"exercise_price":123.26,"exercise_date":"2026-05-15","expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":1800},"source":{"system":"sec-edgar","filing":"0000950170-25-074761","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000095017025074761/ownership.xml","form_type":"4"}},{"id":1144325,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-20T00:26:29.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":973,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Konstantinov was awarded 973 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 15, 2026, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":2894,"source":{"system":"sec-edgar","filing":"0000950170-25-074761","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000095017025074761/ownership.xml","form_type":"4"}},{"id":1510031,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-20T23:27:43.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":1376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full on the earlier of May 16, 2025, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined."}],"balance_after":1376,"derivative":{"exercise_price":171.03,"exercise_date":"2025-05-16","expiration_date":"2034-05-16","underlying":"Common Stock","underlying_shares":1376},"source":{"system":"sec-edgar","filing":"0000950170-24-062614","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000095017024062614/ownership.xml","form_type":"4"}},{"id":1510030,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-20T23:27:43.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Konstantinov was awarded 701 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 16, 2025, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":1921,"source":{"system":"sec-edgar","filing":"0000950170-24-062614","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000095017024062614/ownership.xml","form_type":"4"}},{"id":1883666,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-23T01:19:26.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":1487,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full on the earlier of May 18, 2024, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined."}],"balance_after":1487,"derivative":{"exercise_price":156.63,"exercise_date":"2024-05-18","expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":1487},"source":{"system":"sec-edgar","filing":"0000899243-23-013665","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924323013665/doc4.xml","form_type":"4"}},{"id":1883665,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-23T01:19:26.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Konstantinov was awarded 686 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 18, 2024, one year from the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":1220,"source":{"system":"sec-edgar","filing":"0000899243-23-013665","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924323013665/doc4.xml","form_type":"4"}},{"id":1934713,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2023-03-30T17:13:35.000Z","date":"2023-03-28","kind":"sale","planned":false,"acquired":false,"shares":1932,"price":0.2,"value":386.4,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-23-011029","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659352/000095017023011029/ownership.xml","form_type":"4"}},{"id":1934712,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2023-03-30T17:13:35.000Z","date":"2023-03-28","kind":"sale","planned":false,"acquired":false,"shares":7432,"price":0.2001,"value":1487.1432,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 1,932 shares of common stock acquired on June 30, 2022 and December 30, 2022 under the Issuer's Employee Stock Purchase Plan (ESPP)."}],"balance_after":1932,"source":{"system":"sec-edgar","filing":"0000950170-23-011029","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659352/000095017023011029/ownership.xml","form_type":"4"}},{"id":2002808,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-21T16:32:01.000Z","date":"2023-02-16","kind":"exercise","acquired":false,"shares":4200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 16, 2022, the reporting person was granted 16,800 RSUs, vesting in four equal installments every six months beginning on the six month anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 16, 2022, the reporting person was granted 16,800 RSUs, vesting in four equal installments every six months beginning on the six month anniversary of the grant date."}],"balance_after":8400,"derivative":{"underlying":"Common Stock","underlying_shares":4200},"source":{"system":"sec-edgar","filing":"0000899243-23-005696","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1659352/000089924323005696/doc4.xml","form_type":"4"}},{"id":2002807,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-21T16:32:01.000Z","date":"2022-08-16","kind":"exercise","acquired":false,"shares":4200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 16, 2022, the reporting person was granted 16,800 RSUs, vesting in four equal installments every six months beginning on the six month anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 16, 2022, the reporting person was granted 16,800 RSUs, vesting in four equal installments every six months beginning on the six month anniversary of the grant date."}],"balance_after":12600,"derivative":{"underlying":"Common Stock","underlying_shares":4200},"source":{"system":"sec-edgar","filing":"0000899243-23-005696","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1659352/000089924323005696/doc4.xml","form_type":"4"}},{"id":2002806,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2023-02-21T16:32:01.000Z","date":"2023-02-17","kind":"sale","acquired":false,"shares":1391,"price":0.5922,"value":823.7502,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of RSUs pursuant to a \"sell to cover\" provision included in the RSU Agreement."}],"balance_after":7432,"source":{"system":"sec-edgar","filing":"0000899243-23-005696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1659352/000089924323005696/doc4.xml","form_type":"4"}},{"id":2002805,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2023-02-21T16:32:01.000Z","date":"2023-02-16","kind":"exercise","acquired":true,"shares":4200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":8823,"source":{"system":"sec-edgar","filing":"0000899243-23-005696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659352/000089924323005696/doc4.xml","form_type":"4"}},{"id":2002804,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2023-02-21T16:32:01.000Z","date":"2022-08-17","kind":"sale","acquired":false,"shares":1308,"price":2.2129,"value":2894.4732,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of RSUs pursuant to a \"sell to cover\" provision included in the RSU Agreement."}],"balance_after":4623,"source":{"system":"sec-edgar","filing":"0000899243-23-005696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659352/000089924323005696/doc4.xml","form_type":"4"}},{"id":2002803,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2023-02-21T16:32:01.000Z","date":"2022-08-16","kind":"exercise","acquired":true,"shares":4200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":5931,"source":{"system":"sec-edgar","filing":"0000899243-23-005696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659352/000089924323005696/doc4.xml","form_type":"4"}},{"id":2044660,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-26T16:15:52.000Z","date":"2023-01-24","kind":"grant","acquired":true,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on January 24, 2024, with the remainder vesting in 12 equal quarterly installments thereafter."}],"balance_after":145000,"derivative":{"exercise_price":0.74,"expiration_date":"2033-01-23","underlying":"Common Stock","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0000899243-23-002755","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659352/000089924323002755/doc4.xml","form_type":"4"}},{"id":2048396,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-23T16:36:39.000Z","date":"2023-01-19","kind":"exercise","acquired":false,"shares":2800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 19, 2022, the reporting person was granted 8,400 RSUs, vesting in three equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 19, 2022, the reporting person was granted 8,400 RSUs, vesting in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":5600,"derivative":{"underlying":"Common Stock","underlying_shares":2800},"source":{"system":"sec-edgar","filing":"0000899243-23-002402","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659352/000089924323002402/doc4.xml","form_type":"4"}},{"id":2048395,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2023-01-23T16:36:39.000Z","date":"2023-01-20","kind":"sale","acquired":false,"shares":1069,"price":0.5752,"value":614.8888,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of RSUs pursuant to a \"sell to cover\" provision included in the RSU Agreement."}],"balance_after":1731,"source":{"system":"sec-edgar","filing":"0000899243-23-002402","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659352/000089924323002402/doc4.xml","form_type":"4"}},{"id":2048394,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2023-01-23T16:36:39.000Z","date":"2023-01-19","kind":"exercise","acquired":true,"shares":2800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":2800,"source":{"system":"sec-edgar","filing":"0000899243-23-002402","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659352/000089924323002402/doc4.xml","form_type":"4"}},{"id":2153856,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2022-09-20T16:15:33.000Z","date":"2022-09-16","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 16, 2022, the reporting person was granted 80,000 restricted stock units, vesting on June 30, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On September 16, 2022, the reporting person was granted 80,000 restricted stock units, vesting on June 30, 2023."}],"balance_after":80000,"derivative":{"underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0000899243-22-031586","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659352/000089924322031586/doc4.xml","form_type":"4"}},{"id":2252356,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-01T00:23:50.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":2498,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares vest in equal annual instalments over a three-year period with each such vesting date occurring on the earlier of the anniversary of the grant date or the date of the annual meeting of the Company's shareholders of the applicable year of such three-year period."}],"balance_after":2498,"derivative":{"exercise_price":159.17,"exercise_date":"2023-05-26","expiration_date":"2032-05-26","underlying":"Common Stock","underlying_shares":2498},"source":{"system":"sec-edgar","filing":"0000899243-22-020283","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924322020283/doc4.xml","form_type":"4"}},{"id":2252355,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-01T00:23:50.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":1298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full on May 26, 2023, one year from grant date."}],"balance_after":1298,"derivative":{"exercise_price":159.17,"exercise_date":"2023-05-26","expiration_date":"2032-05-26","underlying":"Common Stock","underlying_shares":1298},"source":{"system":"sec-edgar","filing":"0000899243-22-020283","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924322020283/doc4.xml","form_type":"4"}},{"id":2252354,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-01T00:23:50.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Konstantinov was awarded 534 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 26, 2023, one year from the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":534,"source":{"system":"sec-edgar","filing":"0000899243-22-020283","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924322020283/doc4.xml","form_type":"4"}},{"id":2384714,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-18T16:05:36.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":16800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 16, 2022, the reporting person was granted 16,800 restricted stock units, vesting in four equal installments every six months beginning on the six month anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 16, 2022, the reporting person was granted 16,800 restricted stock units, vesting in four equal installments every six months beginning on the six month anniversary of the grant date."}],"balance_after":16800,"derivative":{"underlying":"Common Stock","underlying_shares":16800},"source":{"system":"sec-edgar","filing":"0000899243-22-007004","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659352/000089924322007004/doc4.xml","form_type":"4"}},{"id":2384713,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-18T16:05:36.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":11200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on February 16, 2023, with the remainder vesting in 12 equal quarterly installments thereafter."}],"balance_after":11200,"derivative":{"exercise_price":5.21,"expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":11200},"source":{"system":"sec-edgar","filing":"0000899243-22-007004","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659352/000089924322007004/doc4.xml","form_type":"4"}},{"id":2428507,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-21T16:05:27.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":8400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 19, 2022, the reporting person was granted 8,400 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 19, 2022, the reporting person was granted 8,400 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":8400,"derivative":{"underlying":"Common Stock","underlying_shares":8400},"source":{"system":"sec-edgar","filing":"0000899243-22-002861","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659352/000089924322002861/doc4.xml","form_type":"4"}},{"id":2428506,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-21T16:05:27.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on January 19, 2023, with the remainder vesting in 12 equal quarterly installments thereafter."}],"balance_after":42000,"derivative":{"exercise_price":7.21,"expiration_date":"2032-01-18","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0000899243-22-002861","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659352/000089924322002861/doc4.xml","form_type":"4"}},{"id":2557314,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-28T16:05:42.000Z","date":"2021-06-08","kind":"exercise","acquired":true,"shares":7276,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The transactions reported in this Form 4 were inadvertently reported late due to an administrative oversight related to communications of the transactions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option are fully vested."}],"balance_after":92978,"derivative":{"exercise_price":3.29,"expiration_date":"2026-02-18","underlying":"Common Stock","underlying_shares":7276},"source":{"system":"sec-edgar","filing":"0000899243-21-038063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1659352/000089924321038063/doc4.xml","form_type":"4"}},{"id":2557313,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-09-28T16:05:42.000Z","date":"2021-06-08","kind":"sale","acquired":false,"shares":1004,"price":26.0415,"value":26145.666,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The transactions reported in this Form 4 were inadvertently reported late due to an administrative oversight related to communications of the transactions."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a previously adopted Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $26.00 to $26.12 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-038063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659352/000089924321038063/doc4.xml","form_type":"4"}},{"id":2557312,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-09-28T16:05:42.000Z","date":"2021-06-08","kind":"sale","acquired":false,"shares":6272,"price":25.531,"value":160130.432,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The transactions reported in this Form 4 were inadvertently reported late due to an administrative oversight related to communications of the transactions."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a previously adopted Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $25.00 to $25.99 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":1004,"source":{"system":"sec-edgar","filing":"0000899243-21-038063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659352/000089924321038063/doc4.xml","form_type":"4"}},{"id":2557311,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-09-28T16:05:42.000Z","date":"2021-06-08","kind":"exercise","acquired":true,"shares":7276,"price":3.29,"value":23938.04,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The transactions reported in this Form 4 were inadvertently reported late due to an administrative oversight related to communications of the transactions."}],"balance_after":7276,"source":{"system":"sec-edgar","filing":"0000899243-21-038063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659352/000089924321038063/doc4.xml","form_type":"4"}},{"id":2894730,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-26T16:52:47.000Z","date":"2021-01-22","kind":"grant","acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on January 22, 2022, with the remainder vesting in 12 equal quarterly installments thereafter."}],"balance_after":32000,"derivative":{"exercise_price":26.6,"expiration_date":"2031-01-21","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0000899243-21-003317","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659352/000089924321003317/doc4.xml","form_type":"4"}}]}